about
Production and clinical development of nanoparticles for gene deliverySelf-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic NanoparticlesNanoparticles for imaging and treating brain cancerHigh-density lipoproteins for the systemic delivery of short interfering RNA.Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria.Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.Progress and perspective of inorganic nanoparticle-based siRNA delivery systemsWhole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers.siRNA: a new approach to target neuropathic pain.Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA.Nanocarriers for vascular delivery of anti-inflammatory agentsBeyond traditional pharmacology: new tools and approaches.Recent advances in siRNA delivery.Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.Therapeutic Potentials of Noncoding RNAs: Targeted Delivery of ncRNAs in Cancer Cells.Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.Kinesin spindle protein SiRNA slows tumor progression.Recent developments in nanoparticle-based siRNA delivery for cancer therapy.Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacyQuantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterolDendrimers as carriers for siRNA delivery and gene silencing: a review.RNAi-based therapies for Huntington’s disease: delivery challenges and opportunitiesPreparation of particulate polymeric therapeutics for medical applicationsDelivery siRNA with a novel gene vector for glioma therapy by targeting Gli1Recent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent
P2860
Q26752803-B71D426D-5B0A-4101-A9E4-10CE951FB3F7Q27027078-87746C10-255D-41FC-8B8B-C84B42345DB7Q28394053-DFD81776-9D5E-4892-A8E1-7E3F77340004Q33786171-10AA58EA-4191-459C-9CF2-124280A7D90CQ34217027-86799A9A-644C-4078-BFDF-66B595F29AD6Q35560995-3D344C6D-A0BE-4BAB-A2C5-4BB4605722DBQ35688089-EFC77ED3-098A-423B-9DCE-918238B0DC7EQ36161060-B4A28407-3ED8-45D9-BE42-92CA6BE1F5E2Q37021426-39D8C371-DE92-4A1F-B7EF-9E7B1277133BQ37122097-753614C7-237C-4ADD-82D6-376923842A36Q37370429-8C3CA77A-E388-4D59-A47D-DC49D970C650Q37922198-F6DEF387-32A4-487F-BFA6-0068343DB79FQ38017713-3701C0DD-F84A-4898-96B6-4B19B27A36A0Q38051429-790C9BE6-E8A8-4353-8125-0B7DEE5F0D80Q38167284-A769EA02-53EC-41DE-A5D2-881F458DFC0EQ38168355-72BD9541-E608-445F-ABAC-39D6887AD846Q38176037-F402CEC0-6CA6-414B-9CC5-D229B989BECDQ38311702-DD4EA566-EBA0-4356-A8A1-90EFAC442A0CQ38648525-B659CE57-527F-482D-840A-B888B933977EQ38734500-BD19049A-9240-4399-8853-9AA15DAC6A11Q38885511-436EAC75-6466-4D49-8111-22D743ECF6B6Q38930049-68311E1A-A930-4796-BB92-069D669DCA06Q38952654-2400C396-1A33-4D96-ABA4-89120836BB80Q39066848-1B832B7E-2C85-4A84-8023-CF64BB6D9888Q39354689-56FE53D4-8FF6-460F-AB03-8F54AB172002Q39386763-DB096DA1-1487-45F1-A9C8-58FBB9AFB716Q39428098-2C461A85-A870-45F8-8E3A-BE06997B8F8BQ41235240-99A9A59C-F32D-4306-8C86-83DBD6AEA9EFQ53663170-31F1CE0B-5882-4C7E-B922-527D2B7951F2Q56192358-F3CD251D-BA25-40D8-AFFE-8E96DC534B59Q57498734-82D03E03-AC49-4689-A835-B8EBFE734240Q58700908-9E114393-C280-4F4C-B78D-D3E1181DEAD9Q59113665-15FE5AEB-8885-4FC4-99AF-3FA8312E6B2E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances of siRNA delivery by nanoparticles.
@en
Recent advances of siRNA delivery by nanoparticles.
@nl
type
label
Recent advances of siRNA delivery by nanoparticles.
@en
Recent advances of siRNA delivery by nanoparticles.
@nl
prefLabel
Recent advances of siRNA delivery by nanoparticles.
@en
Recent advances of siRNA delivery by nanoparticles.
@nl
P2093
P2860
P1476
Recent advances of siRNA delivery by nanoparticles.
@en
P2093
Sandy Naguib
Xudong Yuan
Zhiqian Wu
P2860
P304
P356
10.1517/17425247.2011.559223
P407
P577
2011-03-18T00:00:00Z